This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $162,000.00 to the University of South Carolina to develop and implement an equity-driven research training program. The program aims to build capacity and expertise in integrating community engagement, health communication, and implementation science research to advance the science on Alzheimer's disease and related dementias (ADRD) disparities and outcomes, particularly among...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) in the amount of $297,000.00 will support a mixed methods study to understand the challenges and benefits of delivering new Alzheimer's disease (AD) drugs equitably to African American and white patients in Alabama. The objective is to assess access to care barriers, perceived value, and costs and benefits of new AD drugs for these two populations. In the initial R61 planning phase, the University of...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will investigate the impact of Historically Black Colleges and Universities (HBCUs) on late-life cognition and Alzheimer's disease and related dementias (ADRD) outcomes among Black adults. The $520,040.19 award, effective September 1, 2024 through May 31, 2027, will leverage three large national panel datasets to evaluate the causal effects of HBCU attendance and proximity, as well as state/federal...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $1,550,751 will support an investigation of the influences of historical, enduring, and contemporary structural racism on racial disparities in cognitive aging, functional decline, and frailty trajectories. The research will leverage data from the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) epidemiological cohort study and will involve up to 800 participants tracked...
This $129,411 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop and evaluate novel digital initiatives to improve the inclusion of minoritized older adults, specifically Black/African American and Latinx/a/o populations, in Alzheimer's disease and related dementia (AD/ADRD) research. The key objectives are to: 1) Identify theory-based factors associated with greater intention to participate in different AD/ADRD research settings among this...
This federal Project Grant award for $729,567, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), will fund a study to investigate the causal impacts of two key childhood environmental conditions - school quality and infectious disease exposure - on adult health and mortality outcomes. The study aims to construct a novel dataset linking individual-level childhood environment factors to longevity, in order to examine how these modifiable conditions affect schooling,...
This federal Project Grant award of $331,439 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a research project titled "Health Equity in Alzheimer's Treatment (HEAT)". The key objectives of the project are to: Use qualitative and quantitative methods to better understand the preferences, diagnostic/monitoring burden, and cost factors affecting the real-world effectiveness of new anti-amyloid Alzheimer's medications in predominantly Black and low-income...
This Project Grant award of $794,956 from the National Institute on Aging (NIA) Aging Research program (CFDA 93.866) aims to evaluate the effectiveness of Transitional Care Management (TCM) and Chronic Care Management (CCM) services in improving health outcomes and reducing healthcare costs for older adult Medicare beneficiaries. The research will employ a target trial emulation approach to compare TCM and CCM services to usual care, with a focus on outcomes such as home time, survival, and...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $608,731 to Brown University to study the impact of Medicare and Medicaid financial policies on post-acute and long-term care utilization and outcomes for persons living with Alzheimer's disease and related dementias (ADRD). The 5-year project aims to leverage Medicare claims and clinical assessment data to examine: 1) changes in nursing home and home health service use by ADRD patients amid...
This $322,286 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to advance health equity in the use of novel treatments for Alzheimer's disease and related dementias (ADRD). The primary objectives are to: Conduct focus groups with diverse individuals affected by ADRD to understand their medication decision-making processes. Design and administer discrete choice experiments to learn how different treatment attributes are...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $161,270 to the University of Alabama at Birmingham (UAB) to develop a national Community-Based Participatory Research (CBPR) training program focused on improving health equity for minority older adults. The overarching goal is to build a cadre of geriatrics, gerontology, and palliative care researchers, clinicians, and administrators across the U.S. with the skills to leverage CBPR to foster impactful and sustained healthcare system change for minoritized older adult populations. Key objectives include: (1) building the CBPR training program, (2) measuring program outcomes, and (3) developing a sustainability plan. By training a diverse group of professionals in CBPR approaches tailored to aging research and care, this award aims to address systemic healthcare disparities impacting minority older adults and catalyze the development of culturally appropriate interventions.